SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-20-001575
Filing Date
2020-02-04
Accepted
2020-02-04 16:51:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13-ga.htm SC 13G/A 65308
  Complete submission text file 0001493152-20-001575.txt   66626
Mailing Address C/O ETON PHARMACEUTICALS, INC. 21925 W FIELD PKWY #235 DEER PARK IL 60010
Business Address
BRYNJELSEN SEAN (Filed by) CIK: 0001669976 (see all company filings)

Type: SC 13G/A

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Subject) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90726 | Film No.: 20574557
SIC: 2834 Pharmaceutical Preparations